Largest Drug Manufacturers - General Companies by Market Cap
Largest Drug Manufacturers - General companies by market cap. The Drug Manufacturers - General sector has 87 publicly listed stocks with a combined market cap of $7.42 Trillion. Eli Lilly and Company leads the sector with a market cap of $1.06 Trillion. This ranking covers all Drug Manufacturers - General stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Drug Manufacturers - General Stocks by Market Capitalization (November 2026)
Top Drug Manufacturers - General stocks by market capitalization as of November 2026, covering 87 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Eli Lilly and Company
NYSE:LLY |
$1.06 Trillion | $1.06 Trillion | USA | $1354.00 | -0.79% | -1.43% | 67.60 Million |
| 2 |
Eli Lilly and Company
SA:LILY34 |
$853.51 Billion | R$4.35 Trillion | Brazil | R$153.70 | +0.70% | -0.16% | 250.45K |
| 3 |
Johnson & Johnson
NYSE:JNJ |
$574.95 Billion | $574.95 Billion | USA | $276.22 | +1.43% | +0.37% | 184.50 Million |
| 4 |
AbbVie Inc
NYSE:ABBV |
$356.49 Billion | $356.49 Billion | USA | $291.31 | +1.07% | +0.18% | 129.68 Million |
| 5 |
Novartis AG
MX:NVSN |
$331.27 Billion | MX$5.76 Trillion | Mexico | MX$3016.73 | +0.24% | +8.59% | 3.04K |
| 6 |
Merck & Company Inc
NYSE:MRK |
$316.95 Billion | $316.95 Billion | USA | $146.73 | -0.14% | +0.27% | 244.16 Million |
| 7 |
AstraZeneca PLC
MX:AZNN |
$290.50 Billion | MX$5.05 Trillion | Mexico | MX$1628.00 | +1.25% | -4.81% | 6.50K |
| 8 |
AstraZeneca PLC
NASDAQ:AZN |
$282.04 Billion | $282.04 Billion | USA | $187.03 | -1.43% | +1.12% | 43.91 Million |
| 9 |
Novartis AG ADR
NYSE:NVS |
$281.41 Billion | $281.41 Billion | USA | $147.48 | +0.11% | -3.02% | 34.68 Million |
| 10 |
Roche Holding AG
SW:ROG |
$256.43 Billion | CHF202.83 Billion | Switzerland | CHF320.70 | +0.79% | -8.76% | 28.40 Million |
| 11 |
AstraZeneca PLC
F:ZEGA |
$252.57 Billion | €216.04 Billion | Germany | €75.50 | -3.82% | -2.58% | 3.45K |
| 12 |
Roche Holding AG
SW:ROP |
$250.86 Billion | CHF198.42 Billion | Switzerland | CHF390.30 | -0.36% | -2.84% | 25.62 Million |
| 13 |
AstraZeneca PLC
NYSE:AZN |
$246.25 Billion | $246.25 Billion | USA | $186.43 | -0.22% | +6.90% | 76.94 Million |
| 14 |
Novartis AG
SW:NOVN |
$216.30 Billion | CHF171.09 Billion | Switzerland | CHF133.08 | -0.78% | +0.59% | 84.67 Million |
| 15 |
Amgen Inc
NASDAQ:AMGN |
$198.99 Billion | $198.99 Billion | USA | $460.42 | +0.03% | -0.07% | 66.06 Million |
| 16 |
Gilead Sciences Inc
NASDAQ:GILD |
$182.40 Billion | $182.40 Billion | USA | $166.89 | -0.41% | +0.77% | 161.54 Million |
| 17 |
Pfizer Inc
NYSE:PFE |
$151.73 Billion | $151.73 Billion | USA | $29.39 | -1.64% | -1.87% | 818.09 Million |
| 18 |
Pfizer Inc
SA:PFIZ34 |
$147.67 Billion | R$752.56 Billion | Brazil | R$33.09 | -0.78% | -2.25% | 179.03K |
| 19 |
Novo Nordisk A/S
CO:NOVO-B |
$142.15 Billion | Dkr908.54 Billion | Denmark | Dkr269.45 | -0.66% | +3.50% | 119.32 Million |
| 20 |
Bristol-Myers Squibb Company
NYSE:BMY |
$126.93 Billion | $126.93 Billion | USA | $62.14 | -1.57% | +1.22% | 286.32 Million |
| 21 |
Sanofi
MX:SNYN |
$117.90 Billion | MX$2.05 Trillion | Mexico | MX$855.00 | +0.88% | +17.12% | 8.55K |
| 22 |
GlaxoSmithKline PLC ADR
NYSE:GSK |
$111.15 Billion | $111.15 Billion | USA | $55.63 | -0.13% | -3.77% | 93.36 Million |
| 23 |
GlaxoSmithKline plc
MX:GSKN |
$110.86 Billion | MX$1.93 Trillion | Mexico | MX$960.00 | +0.95% | +10.34% | 3.40K |
| 24 |
Sanofi
F:SNW2 |
$105.72 Billion | €90.43 Billion | Germany | €41.00 | -2.38% | +8.47% | 280.00 |
| 25 |
GSK PLC SP. ADR/2 NEW
F:GS70 |
$101.34 Billion | €86.68 Billion | Germany | €47.20 | +0.00% | -3.28% | 120.00 |
| 26 |
Sanofi SA
PA:SAN |
$95.70 Billion | €81.86 Billion | France | €83.74 | -0.93% | +9.97% | 62.21 Million |
| 27 |
Roche Holding AG
SW:RO |
$53.95 Billion | CHF42.68 Billion | Switzerland | CHF400.00 | +0.25% | -2.30% | 696.99K |
| 28 |
Bayer AG NA
XETRA:BAYN |
$36.43 Billion | €31.16 Billion | Germany | €55.58 | -1.14% | +15.89% | 64.37 Million |
| 29 |
Biogen Inc
NASDAQ:BIIB |
$32.27 Billion | $32.27 Billion | USA | $248.35 | +1.81% | -0.52% | 31.40 Million |
| 30 |
ASTELLAS PHARMA UNSP.ADR
F:YPHA |
$19.55 Billion | €16.72 Billion | Germany | €12.90 | +0.00% | -3.73% | 2.40K |
| 31 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
$12.01 Billion | CN¥82.05 Billion | China | CN¥136.00 | +0.50% | +6.77% | 86.13 Million |
| 32 |
CSPC PHARMACEUT.GR. ADR4
F:CVGU |
$11.04 Billion | €9.44 Billion | Germany | €3.52 | +0.00% | -6.38% | 45.00 |
| 33 |
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
$10.49 Billion | CN¥71.71 Billion | China | CN¥45.08 | -0.33% | +9.15% | 468.00 Million |
| 34 |
CSPC Pharmaceutical Group Limited
F:CVG |
$10.04 Billion | €8.59 Billion | Germany | €0.95 | -0.06% | +4.84% | 11.80K |
| 35 |
Orion Oyj B
HE:ORNBV |
$8.48 Billion | €7.25 Billion | Finland | €102.00 | +0.69% | +3.66% | 4.29 Million |
| 36 |
ORION CORP.B UNSP.ADR 1/2
F:OFK0 |
$8.31 Billion | €7.10 Billion | Germany | €36.20 | -1.09% | -0.55% | 40.00 |
| 37 |
Grifols S.A.
MC:GRF |
$5.55 Billion | €4.75 Billion | Spain | €11.25 | -0.31% | +5.34% | 45.35 Million |
| 38 |
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO |
$4.63 Billion | Rs427.72 Billion | India | Rs2524.80 | +0.98% | +0.39% | 1.42 Million |
| 39 |
Grifols S.A
F:G0FB |
$4.42 Billion | €3.78 Billion | Germany | €7.45 | +0.00% | +5.67% | 0.00 |
| 40 |
GRIFOLS ADR 1/2/EO-50
F:G0F |
$4.21 Billion | €3.60 Billion | Germany | €4.26 | -2.74% | -1.84% | 192.00 |
| 41 |
Orion Oyj A
HE:ORNAV |
$3.76 Billion | €3.22 Billion | Finland | €101.00 | +0.00% | +2.96% | 246.59K |
| 42 |
Organon & Co
NYSE:OGN |
$3.57 Billion | $3.57 Billion | USA | $13.87 | +0.58% | +0.43% | 58.34 Million |
| 43 |
Virbac SA
PA:VIRP |
$3.01 Billion | €2.58 Billion | France | €359.50 | +0.00% | +4.35% | 124.35K |
| 44 |
AstraZeneca PLC
LSE:AZN |
$2.63 Billion | GBX21.60 Trillion | UK | GBX13930.00 | -0.80% | +6.73% | 63.20 Million |
| 45 |
Kalbe Farma Tbk PT
JK:KLBF |
$2.00 Billion | Rp34.16 Trillion | Indonesia | Rp755.00 | -0.66% | +5.59% | 1.34 Billion |
| 46 |
Pfizer Limited
NSE:PFIZER |
$1.91 Billion | Rs176.40 Billion | India | Rs3856.00 | -0.02% | +2.56% | 1.03 Million |
| 47 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
$1.73 Billion | CN¥11.80 Billion | China | CN¥22.54 | -1.96% | +6.32% | 199.04 Million |
| 48 |
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
$1.71 Billion | CN¥11.68 Billion | China | CN¥9.60 | -1.64% | +5.49% | 193.20 Million |
| 49 |
Chongqing Lummy Pharmaceutical
SHE:300006 |
$1.51 Billion | CN¥10.31 Billion | China | CN¥9.76 | -4.69% | -6.87% | 4.96 Billion |
| 50 |
Zhejiang Jolly Pharmaceutical Co Ltd
SHE:300181 |
$1.28 Billion | CN¥8.78 Billion | China | CN¥12.52 | -0.56% | +4.33% | 231.28 Million |
| 51 |
COSMO Pharmaceuticals SA
SW:COPN |
$1.27 Billion | CHF1.01 Billion | Switzerland | CHF58.70 | -2.17% | -3.61% | 790.28K |
| 52 |
Aurora Optoelectronics Co Ltd
SHG:600666 |
$1.19 Billion | CN¥8.12 Billion | China | CN¥2.95 | -2.64% | +1.72% | 1.17 Billion |
| 53 |
NanJing Pharmaceutical Co Ltd
SHG:600713 |
$1.02 Billion | CN¥6.96 Billion | China | CN¥5.32 | +0.38% | +5.77% | 294.47 Million |
| 54 |
Cosmo Pharmaceuticals N.V
F:C43 |
$993.61 Million | €849.89 Million | Germany | €61.20 | -6.71% | +0.82% | 279.00 |
| 55 |
GSK plc
LSE:GSK |
$921.45 Million | GBX7.57 Trillion | UK | GBX1890.00 | +0.00% | +4.19% | 184.91 Million |
| 56 |
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
$911.82 Million | CN¥6.23 Billion | China | CN¥12.73 | -1.93% | +4.43% | 207.67 Million |
| 57 |
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
$851.86 Million | Rs78.77 Billion | India | Rs3420.20 | -0.69% | -1.38% | 803.95K |
| 58 |
Sanofi India Limited
NSE:SANOFI |
$817.71 Million | Rs75.61 Billion | India | Rs3283.10 | -2.75% | +2.93% | 811.84K |
| 59 |
Zhejiang Int'L Group Co Ltd
SHE:000411 |
$746.13 Million | CN¥5.10 Billion | China | CN¥9.77 | -1.11% | +0.10% | 152.37 Million |
| 60 |
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
$698.96 Million | CN¥4.78 Billion | China | CN¥43.73 | -5.04% | +3.33% | 75.30 Million |
| 61 |
Hunan Jingfeng Pharmaceutical
SHE:000908 |
$691.33 Million | CN¥4.72 Billion | China | CN¥5.37 | -2.36% | +5.92% | 281.23 Million |
| 62 |
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281 |
$648.11 Million | CN¥4.43 Billion | China | CN¥40.90 | -2.15% | +4.68% | 47.93 Million |
| 63 |
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507 |
$608.88 Million | CN¥4.16 Billion | China | CN¥11.67 | -1.93% | +3.27% | 119.74 Million |
| 64 |
SENORES PHARMACEUTICALS L
NSE:SENORES |
$578.24 Million | Rs53.47 Billion | India | Rs1161.00 | -2.26% | -4.77% | 8.56 Million |
| 65 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613 |
$448.89 Million | CN¥3.07 Billion | China | CN¥6.40 | -2.59% | +2.24% | 1.28 Billion |
| 66 |
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
$333.26 Million | R$1.70 Billion | Brazil | R$11.37 | +6.26% | +7.26% | 36.80 Million |
| 67 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671 |
$319.16 Million | CN¥2.18 Billion | China | CN¥17.91 | +0.62% | -1.81% | 69.15 Million |
| 68 |
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
$304.60 Million | CN¥2.08 Billion | China | CN¥6.23 | -1.11% | -3.86% | 112.51 Million |
| 69 |
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
$285.42 Million | CN¥1.95 Billion | China | CN¥5.67 | -1.39% | -1.39% | 164.12 Million |
| 70 |
Amarin Corporation PLC
NASDAQ:AMRN |
$243.45 Million | $243.45 Million | USA | $11.61 | +0.30% | -8.83% | 1.89 Million |
| 71 |
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
$236.90 Million | CN¥1.62 Billion | China | CN¥3.19 | -0.62% | +1.59% | 55.54 Million |
| 72 |
NGL Fine-Chem Limited
NSE:NGLFINE |
$189.24 Million | Rs17.50 Billion | India | Rs2832.40 | -0.97% | +8.40% | 186.34K |
| 73 |
TTK Healthcare Limited
NSE:TTKHLTCARE |
$139.92 Million | Rs12.94 Billion | India | Rs915.65 | +0.03% | -12.72% | 600.21K |
| 74 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750 |
$67.16 Million | ₩99.10 Billion | Korea | ₩1975.00 | -3.19% | -4.82% | 54.41 Million |
| 75 |
PharmGen Science Inc
KO:004720 |
$43.81 Million | ₩64.64 Billion | Korea | ₩2950.00 | +2.08% | +7.27% | 480.48K |
| 76 |
Singbao International Co Ltd
TWO:6130 |
$36.73 Million | NT$1.17 Billion | Taiwan | NT$24.65 | -3.52% | +12.30% | 7.22 Million |
| 77 |
Nasus Pharma Ltd.
NYSE MKT:NSRX |
$33.96 Million | $33.96 Million | USA | $2.90 | +1.05% | -2.36% | 2.69 Million |
| 78 |
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA |
$23.97 Million | $23.97 Million | USA | $0.57 | +5.61% | -0.19% | 2.65 Million |
| 79 |
Yung Zip Chemical Ind Co Ltd
TWO:4102 |
$23.56 Million | NT$747.90 Million | Taiwan | NT$17.65 | -1.94% | -5.36% | 677.05K |
| 80 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904 |
$22.61 Million | $22.61 Million | China | $0.41 | -1.20% | +3.77% | 3.00 Million |
| 81 |
Korean Drug Co. Ltd
KQ:014570 |
$20.40 Million | ₩30.10 Billion | Korea | ₩2780.00 | -0.71% | -2.11% | 183.16K |
| 82 |
BCWORLD PHARM. Co. Ltd
KQ:200780 |
$19.12 Million | ₩28.22 Billion | Korea | ₩2760.00 | -1.95% | -2.13% | 199.50K |
| 83 |
Lipidor Ab
ST:LIPI |
$18.82 Million | Skr174.88 Million | Sweden | Skr0.22 | +0.00% | +0.00% | 0.00 |
| 84 |
Scilex Holding Company
NASDAQ:SCLX |
$11.96 Million | $11.96 Million | USA | $1.70 | +0.00% | -17.48% | 1.08 Million |
| 85 |
Medicus Pharma Ltd. Common Stock
NASDAQ:MDCX |
$10.20 Million | $10.20 Million | USA | $1.87 | +2.19% | -13.02% | 35.35 Million |
| 86 |
Chorokbaem Healthcare Co Ltd
KO:118000 |
$8.85 Million | ₩13.05 Billion | Korea | ₩760.00 | -10.38% | -41.45% | 2.27 Million |
| 87 |
Firebrick Pharma Ltd
AU:FRE |
$5.69 Million | AU$8.04 Million | Australia | AU$0.03 | +0.00% | +0.00% | 3.54 Million |
How Drug Manufacturers - General Companies Are Ranked by Market Cap
Drug Manufacturers - General companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Drug Manufacturers - General industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - general corporations. View all industries